Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Natural Killer Cell Lymphoblastic Leukemia/Lymphoma”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT00789776
What this trial is testing

Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAggressive Non-Hodgkin Lymphoma+13 more
Fred Hutchinson Cancer Center 41
Early research (Phase 1)Active Not RecruitingNCT05020678
What this trial is testing

NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers

Who this might be right for
Lymphoma, Non-HodgkinB-cell Acute Lymphoblastic LeukemiaLarge B-cell Lymphoma+7 more
Nkarta, Inc. 150
Early research (Phase 1)Study completedNCT02185781
What this trial is testing

Phase I Study of Adoptive Immunotherapy With Enriched and Expanded Autologous Natural Killer (NK) Cells for Patients With Ph+ Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Lymphoblastic LeukemiaComplete Hematologic Remission (CHR)Persistent/Recurrent Minimal Residual Disease (MRD)
Gruppo Italiano Malattie EMatologiche dell'Adulto 6
Not applicableStudy completedNCT01390597
What this trial is testing

Biomarkers in Tumor Tissue Samples From Patients With Peripheral T-cell Lymphoma or Natural Killer Cell Neoplasms

Who this might be right for
Lymphoma
Eastern Cooperative Oncology Group 32
Early research (Phase 1)Study completedNCT03524235
What this trial is testing

Haploidentical Stem Cell Transplant with Prophylactic Natural Killer DLI for Lymphoma, Multiple Myeloma, and CLL

Who this might be right for
Multiple MyelomaCLLChronic Lymphocytic Leukemia+2 more
Noah Merin 20
Large-scale testing (Phase 3)Study completedNCT00412360
What this trial is testing

Single vs Double Umbilical Cord Blood Transplants in Children With High Risk Leukemia and Myelodysplasia (BMT CTN 0501)

Who this might be right for
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous Leukemia+2 more
Medical College of Wisconsin 224
Testing effectiveness (Phase 2)Study completedNCT03056339
What this trial is testing

Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies

Who this might be right for
B-Lymphoid MalignanciesAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+1 more
M.D. Anderson Cancer Center 49
Testing effectiveness (Phase 2)Ended earlyNCT02259348
What this trial is testing

Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation

Who this might be right for
Acute Lymphoblastic Leukemia (ALL)Acute Myeloid Leukemia (AML)Myeloid Sarcoma+4 more
St. Jude Children's Research Hospital 12
Testing effectiveness (Phase 2)Ended earlyNCT02991898
What this trial is testing

Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaBurkitt LymphomaNatural Killer Cell Malignancies+15 more
Masonic Cancer Center, University of Minnesota 3
Testing effectiveness (Phase 2)Study completedNCT00416351
What this trial is testing

Clofarabine in Treating Patients With T-Cell or Natural Killer-Cell Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment

Who this might be right for
LeukemiaLymphomaSmall Intestine Cancer
Memorial Sloan Kettering Cancer Center 29
Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Study completedNCT02280525
What this trial is testing

Cord Blood Natural Killer (NK) Cells in Leukemia/Lymphoma

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 8
Testing effectiveness (Phase 2)Ended earlyNCT00941928
What this trial is testing

Haploidentical Natural Killer (NK) Cells With Epratuzumab for Relapsed Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
LeukemiaPediatric Cancer
M.D. Anderson Cancer Center 2
Early research (Phase 1)Study completedNCT00697671
What this trial is testing

Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaChronic Myelogenous LeukemiaJuvenile Myelomonocytic Leukemia+2 more
St. Jude Children's Research Hospital 48
Testing effectiveness (Phase 2)Temporarily pausedNCT06761677
What this trial is testing

A Phase 1b/2 Study of Intravenous Brincidofovir in Patients With Relapsed or Refractory Lymphoma and Relapsed or Refractory Extranodal Natural Killer/T-cell Lymphoma

Who this might be right for
Relapsed or Refractory Lymphoma Including ENKL
SymBio Pharmaceuticals 43
Not applicableUnknownNCT06160115
What this trial is testing

The Role of NK Cells to Detect Blood Infection in ALL.

Who this might be right for
Acute Lymphoblastic LeukemiaBloodstream Infection
Assiut University 56
Not applicableEnded earlyNCT00918658
What this trial is testing

Study of Natural Killer Cells in Bone Marrow and Blood Samples From Patients With and Without Hematologic Cancer

Who this might be right for
LeukemiaMultiple Myeloma and Plasma Cell Neoplasm
Case Comprehensive Cancer Center 34
Early research (Phase 1)Study completedNCT00640796
What this trial is testing

Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, Lymphocytic, Acute, T-CellJuvenile Myelomonocytic Leukemia Lymphoblastic+2 more
St. Jude Children's Research Hospital 22
Testing effectiveness (Phase 2)Ended earlyNCT01944982
What this trial is testing

Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma

Who this might be right for
Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma
Hospital Infantil Universitario Niño Jesús, Madrid, Spain 7
Early research (Phase 1)Not Yet RecruitingNCT07518654
What this trial is testing

Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or Neuroblastoma

Who this might be right for
Leukaemia (Acute Lymphoblastic)Leukaemia (Acute Myeloid)Neuroblastoma+7 more
Michel Duval 12
Load More Results